Abstract
Multiple sclerosis (MS) is an autoimmune demyelinating disease that affects one’s central nervous system. The disease has a number lesion states. One of them is known as active, or enhancing, and indicates that a lesion is under an inflammatory condition. This specific case is of interest to radiologists since it is commonly associated with the period of time a patient suffers most from the effects of MS. To identify which lesions are active, a Gadolinium-based contrast is injected in the patient prior to a magnetic resonance imaging procedure. The properties of the contrast medium allow it to enhance active lesions, making them distinguishable from nonactive ones in T1-w images. However, studies from various research groups in recent years indicate that Gadolinium-based contrasts tend to accumulate in the body after a number of injections. Since a comprehensive understanding of this accumulation is not yet available, medical agencies around the world have been restricting its usage to cases only where it is absolutely necessary. In this work we propose a supervised algorithm to distinguish active from nonactive lesions in FLAIR images, thus eliminating the need for contrast injections altogether. The classification task was performed using textural and enhanced features as input to the XGBoost classifier on a voxel level. Our database comprised 54 MS patients (33 with active lesions and 21 with nonactive ones) with a total of 22 textural and enhanced features obtained from Run Length and Gray Level Co-occurrence Matrices. The average precision, recall and F1-score results in a 6-fold cross-validation for active and nonactive classes were 0.892, 0.968, 0.924 and 0.994, 0.987, 0.991, respectively. Moreover, from a lesion perspective, the algorithm misclassified only 3 active lesions out of 157. These results indicate our tool can be used by physicians to get information about active MS lesions in FLAIR images without using any kind of contrast, thus improving one’s health and also reducing the cost of MRI procedures for MS patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Ardakani, A.A., Nabavi, S., Farzan, A., Najafabad, B.: Quantitative MRI texture analysis in differentiating enhancing and non-enhancing T1-hypointense lesions without application of contrast agent in multiple sclerosis. Czech and Slovak Neurol. Neurosurg. 113(6), 700–707 (2017)
Bennett, J., Lanning, S.: The Netflix prize. In: KDD Cup and Workshop in Conjunction with KDD (2007)
Buades, A., Coll, B., Morel, J.-M.: A non-local algorithm for image denoising. In: IEEE Computer Society Conference on Computer Vision and Pattern Recognition, vol. 2, pp. 60–65 (2005)
Burke, L., Ramalho, M., AlObaidy, M., Chang, E., Jay, M., Semelka, R.: Self-reported gadolinium toxicity: a survey of patients with chronic symptoms. Magn. Reson. Imaging 34, 1078–1080 (2016)
Carass, A., et al.: Longitudinal multiple sclerosis lesion segmentation: resource and challenge. NeuroImage 148, 77–102 (2017)
Castellano, G., Bonilha, L., LM, L., Cendes, F.: Texture analysis of medical images. Clin. Radiol. 59(12), 1061–1069 (2004)
Chen, T., Guestrin, C.: XGBoost: a scalable tree boosting system. In: Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, KDD 2016, pp. 785–794. ACM, New York (2016)
Doyle, A., Elliott, C., Karimaghaloo, Z., Subbanna, N., Arnold, D.L., Arbel, T.: Lesion detection, segmentation and prediction in multiple sclerosis clinical trials. In: Crimi, A., Bakas, S., Kuijf, H., Menze, B., Reyes, M. (eds.) BrainLes 2017. LNCS, vol. 10670, pp. 15–28. Springer, Cham (2018). https://doi.org/10.1007/978-3-319-75238-9_2
Duda, O.R., Hart, P.E., Stork, D.G.: Pattern Classification, 2nd edn. Wiley-Interscience, Hoboken (2000)
European Medicines Agency: EMA reviewing gadolinium contrast agents used in MRI scans (2016). http://bit.ly/EuropeanMedicinesAgency-2016. Accessed 02 Apr 2017
European Medicines Agency: EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans, July 2017. http://bit.ly/EuropeanMedicinesAgency2017. Accessed 01 July 2019
Freire, P.G.L., Ferrari, R.J.: Multiple sclerosis lesion enhancement and white matter region estimation using hyperintensities in FLAIR images. Biomed. Signal Process. Control 49, 338–348 (2019)
Haralick, R., Shanmugam, K., Dinstein, I.: Textural feature for image classification. IEEE Trans. Syst. Man Cybern. 3(6), 610–621 (1973)
Hu, H.H., Pokorney, A., Towbin, R.B., Miller, J.H.: Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams. Pediatr. Radiol. 46(11), 1590–1598 (2016). https://doi.org/10.1007/s00247-016-3646-3
Jonkman, L., et al.: Can MS lesion stages be distinguished with MRI? A portmortem MRI and histopathology study. J. Neurol. 262(4), 1074–1080 (2015). https://doi.org/10.1007/s00415-015-7689-4
Kromrey, M., et al.: Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years. Eur. Radiol. 27(2), 772–777 (2016). https://doi.org/10.1007/s00330-016-4418-z
Lewis, P.A., Spillane, J.E.: Chapter 7 - Multiple Sclerosis. In: Lewis, P.A., Spillane, J.E. (eds.) The Molecular and Clinical Pathology of Neurodegenerative Disease, pp. 221–251. Academic Press (2019)
Litjens, G., et al.: A survey on deep learning in medical image analysis. Med. Image Anal. 42, 60–88 (2017)
Loizou, C.P., Petroudi, S., Seimenis, I., Pantziaris, M., Pattichis, C.S.: Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome. J. Neuroradiol. 2015(42), 99–114 (2014)
Michoux, N., Guillet, A., Rommel, D., Mazzamuto, G., Sindic, C., Duprez, T.: Texture analysis of T2-weighted MR images to assess acute inflammation in brain MS lesions. PLoS One 10(12), e0145497 (2015)
Multiple Sclerosis International Federation: 2013 Atlas of MS (2013). http://www.msif.org/about-us/advocacy/atlas/. Accessed 01 Dec 2015
Nyul, L.G., Udupa, J., Zhang, X.: New variants of a method of MRI scale standardization. IEEE Trans. Med. Imaging 19(2), 143–150 (2000)
Tustison, N., Gee, J.: N4ITK: Nick’s N3 ITK implementation for MRI bias field correction. Penn Image Computing and Science Laboratory (2009)
U.S. Food and Drug Administration: FDA Drug Safety Communication: FDA evaluating the risk of brain deposits with repeated use of gadolinium-based contrast agents for magnetic resonance imaging (MRI) (2015). http://www.fda.gov/Drugs/DrugSafety/ucm455386.htm. Accessed 07 May 2018
U.S. Food and Drug Administration: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings, May 2017. https://www.fda.gov/media/109825/download. Accessed 01 July 2019
U.S. Food and Drug Administration: Update on FDA approach to safety issue of gadolinium retention after administration of gadolinium-based contrast agents, September 2018. https://www.fda.gov/media/116492/download. Accessed 01 July 2019
Beomonte Zobel, B., Quattrocchi, C.C., Errante, Y., Grasso, R.F.: Gadolinium-based contrast agents: did we miss something in the last 25 years? Radiol. Med. 121(6), 478–481 (2015). https://doi.org/10.1007/s11547-015-0614-1
Acknowledgements
This work was supported by the São Paulo Research Foundation - FAPESP (grant numbers 2016/15661-0 and 2018/08826-9).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Freire, P.G.L., Idagawa, M.H., de Oliveira, E.M.L., Abdala, N., Carrete, H., Ferrari, R.J. (2020). Classification of Active Multiple Sclerosis Lesions in MRI Without the Aid of Gadolinium-Based Contrast Using Textural and Enhanced Features from FLAIR Images. In: Gervasi, O., et al. Computational Science and Its Applications – ICCSA 2020. ICCSA 2020. Lecture Notes in Computer Science(), vol 12250. Springer, Cham. https://doi.org/10.1007/978-3-030-58802-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-58802-1_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58801-4
Online ISBN: 978-3-030-58802-1
eBook Packages: Computer ScienceComputer Science (R0)